Research Project

Project Title:

Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.

Project Type:

Clinical Trial, Enrolment ongoing

Disease group(s):

Pediatric CKD & dialysis

Project Summary:

Ascertain the starting dose of Mircera given subcutaneously for the maintenance treatment of anemia in pediatric participants with chronic kidney disease (CKD) on dialysis or not yet on dialysis when switching from stable subcutaneous (SC) maintenance treatment with epoetin alfa, epoetin beta, or darbepoetin alfa.

Lead principal investigator(s):

Giovanni Montini, Milano
Hoffmann -La Roche, Basel

Project Period:

05/2018   -   04/2021

Sponsors:

Industry

ClinicalTrials.gov:

NCT03552393

EudraCT Nr.:

2016-004779-39

« Back to research page